In this study, we further demonstrate the therapeutic efficacy of the orally active small-molecule inhibitors of PM-localization of Ras GTPases, FTS, and its more potent derivative F-FTS, in the rat AIA model of RA. This evidence concerns the gene AKTIP and rheumatoid arthritis.